Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients
Clinical trial NCT00210457 · COMPLETED
Trial details
- NCT number
- NCT00210457
- Sponsor
- Ipsen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-09-01
- Primary completion
- 2002-07-15
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.